These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39234749)

  • 41. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection.
    Whary MT; Avenia JMR; Bravo LE; Lofgren JL; Lertpiriyapong K; Mera-Giler R; Piazuelo MB; Correa P; Peek RM; Wilson KT; Fox JG
    Cancer Epidemiol; 2020 Aug; 67():101726. PubMed ID: 32447242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.
    Toyoda K; Furusyo N; Ihara T; Ikezaki H; Urita Y; Hayashi J
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2117-24. PubMed ID: 22354521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening markers for chronic atrophic gastritis in Chiapas, Mexico.
    Ley C; Mohar A; Guarner J; Herrera-Goepfert R; Figueroa LS; Halperin D; Parsonnet J
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):107-12. PubMed ID: 11219766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
    Wang SS; Guo ZP; Zhao XY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
    Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
    Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
    Wang X; Zhang Q; Han F; Wu Y
    Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
    [No Abstract]   [Full Text] [Related]  

  • 52. Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis.
    Lahner E; Marzinotto I; Lampasona V; Dottori L; Bazzigaluppi E; Brigatti C; Secchi M; Piemonti L; Conti L; Pilozzi E; Davidson HW; Wenzlau JM; Annibale B
    Clin Transl Gastroenterol; 2020 Oct; 11(10):e00240. PubMed ID: 33031196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.
    Ohata H; Kitauchi S; Yoshimura N; Mugitani K; Iwane M; Nakamura H; Yoshikawa A; Yanaoka K; Arii K; Tamai H; Shimizu Y; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2004 Mar; 109(1):138-43. PubMed ID: 14735480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.
    Zagari RM; Rabitti S; Greenwood DC; Eusebi LH; Vestito A; Bazzoli F
    Aliment Pharmacol Ther; 2017 Oct; 46(7):657-667. PubMed ID: 28782119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type I and type II
    Yuan L; Zhao JB; Zhou YL; Qi YB; Guo QY; Zhang HH; Khan MN; Lan L; Jia CH; Zhang YR; Ding SZ
    World J Gastroenterol; 2020 Jul; 26(25):3673-3685. PubMed ID: 32742135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
    Liu H; Fei C; Zhang J
    Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
    Knight T; Wyatt J; Wilson A; Greaves S; Newell D; Hengels K; Corlett M; Webb P; Forman D; Elder J
    Br J Cancer; 1996 Mar; 73(6):819-24. PubMed ID: 8611388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
    Iijima K; Abe Y; Kikuchi R; Koike T; Ohara S; Sipponen P; Shimosegawa T
    World J Gastroenterol; 2009 Feb; 15(7):853-9. PubMed ID: 19230047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Gastrin G-17 Combined with Pepsinogen PGI and PGII on the Early Screening of Gastric Cancer in the Department of Gastroenterology.
    Chen H; Xu H
    Altern Ther Health Med; 2024 Sep; 30(9):141-145. PubMed ID: 39110041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.